# Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)

> **NCT06482489** · — · RECRUITING · sponsor: **University of Lausanne Hospitals** · enrollment: 74 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Siemens Magnetom Free.Max 0.55T (Siemens Healthineers, Erlangen, Germany).

## Key facts

- **NCT ID:** NCT06482489
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482489, "Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06482489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*